Zinaida Perić
Corey Cutler
Daniel WolffSymposium | Current treatment options for SR-cGvHD
Daniel Wolff, University Hospital Regensburg, Regensburg, DE, presented the first session, titled “Current treatment options for SR-cGvHD” at the recent live GvHD Hub symposium.
All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional. If you are a patient or carer, please visit Know GvHD.
TRANSLATE
The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GVHD Hub is an independent medical education platform, sponsored by Medac and supported through independent educational grants from Incyte, Sanofi and Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View GvHD content recommended for you
Symposium series | Evolving treatment strategies in SR‑cGvHD: Optimizing patient selection across current and emerging therapies
On May 22, 2026, the GvHD Hub held a live symposium at the 8th International Chronic Graft-versus-Host Disease Symposium titled ‘Evolving treatment strategies in SR‑cGvHD: Optimizing patient selection across current and emerging therapies’. The symposium was chaired by Zinaida Perić, featured presentations from Daniel Wolff and Corey Cutler, and included an opportunity for audience questions. View each session from the symposium below:
.webp)
Symposium | Impact of clinical manifestations on treatment selection in SR-cGvHD
Corey Cutler, Dana-Farber Cancer Institute, Boston, US, presented the second session, titled Impact of clinical manifestations on treatment selection in SR‑cGvHD, at the recent live GvHD Hub symposium.
Symposium | Emerging treatment strategies for SR-cGvHD
Zinaida Perić, University of Rijeka, HR, presented the third session, titled Emerging treatment strategies for SR-cGvHD, at the recent live GvHD Hub symposium.
Symposium | Panel discussion: Shifting the treatment paradigm in cGvHD
We summarize key points from the panel discussion, titled Shifting the treatment paradigm in cGvHD, at the recent live GvHD Hub symposium.
This educational activity is independently supported by Sanofi. All content was developed by the faculty in collaboration with SES. Funders were allowed no influence.
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
Your opinion matters
What do you consider to be the main potential advantage of mesenchymal stromal cells in the treatment of acute GvHD?